AT

ALANNA TEMME

THE MCMANUS GROUP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
2
last 3 years
Filings
2
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Access and coverage of inpatient drugs in H.R. 2666 - Medicaid VBPs for Patients (MVP) Act. Education and awareness of rare and ultra rare diseases and patient access to orphan drugs.
Medicare/Medicaid · 2024 Q1
Advocating for increased funding for HHS grant programs related to state newborn screening programs.
Budget/Appropriations · 2024 Q1
Education and awareness of rare and ultra rare diseases, patient access to orphan drugs, and newborn screening modernization and reauthorization.
Health Issues · 2024 Q1
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Medicare/Medicaid · 2024 Q1

Clients

2024 · 1 filing
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q1
ORCHARD THERAPEUTICS NORTH AMERICA
1Tlda.gov →
2024 Q1
AVADEL PHARMACEUTICALS
1Tlda.gov →
Showing recent filings · full history on lda.gov